text_1: FDA approves irritable bowel drug.
text_2: The Food and Drug Administration on  Tuesday approved the first U.S. drug to treat irritable bowel  syndrome with constipation (IBS-C) in adult women, a medicine  marketed by Takeda Pharmaceutical Co and its developer, Sucampo  Pharmaceuticals Inc.